Prostate cancer radiogenomics—from imaging to molecular characterization
M Ferro, O de Cobelli, MD Vartolomei… - International Journal of …, 2021 - mdpi.com
Radiomics and genomics represent two of the most promising fields of cancer research,
designed to improve the risk stratification and disease management of patients with prostate …
designed to improve the risk stratification and disease management of patients with prostate …
Advancements in mri-based radiomics and artificial intelligence for prostate cancer: A comprehensive review and future prospects
Simple Summary The integration of artificial intelligence (AI) into radiomic models has
become increasingly popular due to advances in computer-aided diagnosis tools. These …
become increasingly popular due to advances in computer-aided diagnosis tools. These …
Magnetic resonance imaging based radiomic models of prostate cancer: A narrative review
Simple Summary The increasing interest in implementing artificial intelligence in radiomic
models has occurred alongside advancement in the tools used for computer-aided …
models has occurred alongside advancement in the tools used for computer-aided …
Stromal FAP expression is associated with MRI visibility and patient survival in prostate cancer
T Pellinen, K Sandeman, S Blom, R Turkki… - Cancer research …, 2022 - AACR
Some clinically significant prostate cancers are missed by MRI. We asked whether the tumor
stroma in surgically treated localized prostate cancer lesions positive or negative with MRI …
stroma in surgically treated localized prostate cancer lesions positive or negative with MRI …
Should systematic prostatic biopsies be discontinued?
L Klotz - Prostate Cancer and Prostatic Diseases, 2024 - nature.com
Introduction The use of systematic biopsies in addition to targeted biopsies is based on
multiple studies showing that 15–20% of “clinically significant” cancers are missed on …
multiple studies showing that 15–20% of “clinically significant” cancers are missed on …
Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients
G Wu, W Huang, J Xu, W Li, Y Wu, Q Yang… - Journal of Cancer …, 2022 - Springer
Objectives The objective of our study was to investigate whether a phosphatase and tensin
homolog deleted on chromosome 10 (PTEN) expression was associated with dynamic …
homolog deleted on chromosome 10 (PTEN) expression was associated with dynamic …
Biomarkers of prostate bladder and testicular cancers: current use in anatomic pathology and future directions
MA Morini, DA Athanazio, LF Gallas, JM Mota… - Surgical and …, 2024 - Springer
Urologic pathology is rapidly evolving to adopt growing knowledge of molecular pathways
involved in genitourinary neoplasm. Many prognostic and predictive biomarkers are under …
involved in genitourinary neoplasm. Many prognostic and predictive biomarkers are under …
The Genomics and Natural History of MRI-Visible vs MRI-Invisible Prostate Cancers: Clinical Implications
L Klotz - Journal of Urology, 2024 - journals.lww.com
PROSPECTIVE randomized trials have demonstrated that targeted biopsy is superior to
systematic biopsy with respect to the diagnosis of grade group (GG) 2 or higher prostate …
systematic biopsy with respect to the diagnosis of grade group (GG) 2 or higher prostate …